In vitro atomization analysis and evaluation of inhalable sodium sivelestat formulations
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0309721 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Rangdong Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zhuhai College of Science and Technology, Zhuhai, China. Hauptthemen laut MEDLINE: Nebulizers and Vaporizers, Aerosols, Particle Size, Sulfonamides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The purpose of this paper was to study in vitro atomization properties of the self-developed sodium sivelestat for inhalation, evaluate the feasibility of this preparation as an aerosol inhalation, and provide the guidance for the following animal administration experiment. Firstly, in order to ensure accurate, uniform and stable doses of the self-developed product after administration, its atomization performance was analyzed through the testing of fine particle mass and the total emitted dose, and the results of its atomization parameters meet the requirement of inhalation. Next, Atomization characteristics of two commonly used nebulizers, air compressed nebulizer and mesh nebulizer, were studied and compared. The results showed that mesh atomizers have a smaller and more uniform particle size distribution. And then, the experiment of acute lung injury induced by aerosol inhalation of lipopolysaccharide in mice was used to test the therapeutic effect of our self-developed formulation, and compared with the positive control (sodium sivelestat for injection). The results showed that inhalation had a lower concentration and was equally effective than injection of sodium sivelestat. All the results support that the self-developed sodium sivelestat can be used as an aerosol inhaled drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhuhai College of Science and Technology, Zhuhai, China.
- Jinan University, College of Pharmcy, Guangzhou, China.
- Increase Pharma (Hengqin) Institute Co. LTD, Zhuhai, China.
ORCID-Profile: Rangdong Liu
Zitieren
APA
Liu, R., He, A., Xu, Y., Zhou, Y., & Cao, H. (2024). In vitro atomization analysis and evaluation of inhalable sodium sivelestat formulations. PLOS ONE. https://doi.org/10.1371/journal.pone.0309721
Vancouver
Liu R, He A, Xu Y, Zhou Y, Cao H. In vitro atomization analysis and evaluation of inhalable sodium sivelestat formulations. PLOS ONE. 2024. doi:10.1371/journal.pone.0309721
BibTeX
@article{Liu2024,
author = {Liu, Rangdong and He, Aifang and Xu, Yan and Zhou, Yisheng and Cao, Hui},
title = {In vitro atomization analysis and evaluation of inhalable sodium sivelestat formulations},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0309721}
}
EUVIMED